Novo Nordisk lifts 2026 outlook as Wegovy pill surges
TimesLive | 04.11.2026 11:05
Novo Nordisk’s Wegovy weight-loss pill beat third-quarter sales forecasts, and the drug maker lifted its full-year outlook again on Wednesday, boosting efforts to regain lost ground to US rival Eli Lilly.
